Cargando…

Nanofiber-based systems intended for diabetes

Diabetic mellitus (DM) is the most communal metabolic disease resulting from a defect in insulin secretion, causing hyperglycemia by promoting the progressive destruction of pancreatic β cells. This autoimmune disease causes many severe disorders leading to organ failure, lower extremity amputations...

Descripción completa

Detalles Bibliográficos
Autores principales: Maleki, Hassan, Khoshnevisan, Kamyar, Sajjadi-Jazi, Sayed Mahmoud, Baharifar, Hadi, Doostan, Maryam, Khoshnevisan, Nazanin, Sharifi, Farshad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513238/
https://www.ncbi.nlm.nih.gov/pubmed/34641920
http://dx.doi.org/10.1186/s12951-021-01065-2
_version_ 1784583172538761216
author Maleki, Hassan
Khoshnevisan, Kamyar
Sajjadi-Jazi, Sayed Mahmoud
Baharifar, Hadi
Doostan, Maryam
Khoshnevisan, Nazanin
Sharifi, Farshad
author_facet Maleki, Hassan
Khoshnevisan, Kamyar
Sajjadi-Jazi, Sayed Mahmoud
Baharifar, Hadi
Doostan, Maryam
Khoshnevisan, Nazanin
Sharifi, Farshad
author_sort Maleki, Hassan
collection PubMed
description Diabetic mellitus (DM) is the most communal metabolic disease resulting from a defect in insulin secretion, causing hyperglycemia by promoting the progressive destruction of pancreatic β cells. This autoimmune disease causes many severe disorders leading to organ failure, lower extremity amputations, and ultimately death. Modern delivery systems e.g., nanofiber (NF)-based systems fabricated by natural and synthetic or both materials to deliver therapeutics agents and cells, could be the harbinger of a new era to obviate DM complications. Such delivery systems can effectively deliver macromolecules (insulin) and small molecules. Besides, NF scaffolds can provide an ideal microenvironment to cell therapy for pancreatic β cell transplantation and pancreatic tissue engineering. Numerous studies indicated the potential usage of therapeutics/cells-incorporated NF mats to proliferate/regenerate/remodeling the structural and functional properties of diabetic skin ulcers. Thus, we intended to discuss the aforementioned features of the NF system for DM complications in detail. [Image: see text]
format Online
Article
Text
id pubmed-8513238
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85132382021-10-20 Nanofiber-based systems intended for diabetes Maleki, Hassan Khoshnevisan, Kamyar Sajjadi-Jazi, Sayed Mahmoud Baharifar, Hadi Doostan, Maryam Khoshnevisan, Nazanin Sharifi, Farshad J Nanobiotechnology Review Diabetic mellitus (DM) is the most communal metabolic disease resulting from a defect in insulin secretion, causing hyperglycemia by promoting the progressive destruction of pancreatic β cells. This autoimmune disease causes many severe disorders leading to organ failure, lower extremity amputations, and ultimately death. Modern delivery systems e.g., nanofiber (NF)-based systems fabricated by natural and synthetic or both materials to deliver therapeutics agents and cells, could be the harbinger of a new era to obviate DM complications. Such delivery systems can effectively deliver macromolecules (insulin) and small molecules. Besides, NF scaffolds can provide an ideal microenvironment to cell therapy for pancreatic β cell transplantation and pancreatic tissue engineering. Numerous studies indicated the potential usage of therapeutics/cells-incorporated NF mats to proliferate/regenerate/remodeling the structural and functional properties of diabetic skin ulcers. Thus, we intended to discuss the aforementioned features of the NF system for DM complications in detail. [Image: see text] BioMed Central 2021-10-12 /pmc/articles/PMC8513238/ /pubmed/34641920 http://dx.doi.org/10.1186/s12951-021-01065-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Maleki, Hassan
Khoshnevisan, Kamyar
Sajjadi-Jazi, Sayed Mahmoud
Baharifar, Hadi
Doostan, Maryam
Khoshnevisan, Nazanin
Sharifi, Farshad
Nanofiber-based systems intended for diabetes
title Nanofiber-based systems intended for diabetes
title_full Nanofiber-based systems intended for diabetes
title_fullStr Nanofiber-based systems intended for diabetes
title_full_unstemmed Nanofiber-based systems intended for diabetes
title_short Nanofiber-based systems intended for diabetes
title_sort nanofiber-based systems intended for diabetes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513238/
https://www.ncbi.nlm.nih.gov/pubmed/34641920
http://dx.doi.org/10.1186/s12951-021-01065-2
work_keys_str_mv AT malekihassan nanofiberbasedsystemsintendedfordiabetes
AT khoshnevisankamyar nanofiberbasedsystemsintendedfordiabetes
AT sajjadijazisayedmahmoud nanofiberbasedsystemsintendedfordiabetes
AT baharifarhadi nanofiberbasedsystemsintendedfordiabetes
AT doostanmaryam nanofiberbasedsystemsintendedfordiabetes
AT khoshnevisannazanin nanofiberbasedsystemsintendedfordiabetes
AT sharififarshad nanofiberbasedsystemsintendedfordiabetes